GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Exact Sciences Corporation (EXAS) [hlAlert]

Rating:
Outperform
EXAS
up 709.85 %

Exact Sciences Corporation (EXAS) rated Outperform with price target $5 by Robert W. Baird

Posted on: Thursday,  Dec 17, 2009  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Exact Sciences Corporation (NASDAQ: EXAS) on 12/17/2009, when the stock price was $2.74.
Since then, Exact Sciences Corporation has gained 709.85% as of 01/13/2016's recent price of $22.19.
If you would have followed this Robert W. Baird's recommendation on EXAS, you would have gained 709.85% of your investment in 2218 days.

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2009 8:25 AM Buy
None
2.74 5.00
as of 12/31/2009
1 Week up  84.04 %
1 Month up  118.97 %
3 Months   
1 YTD up  118.97 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy